A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children's Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients

Pennesi, E., Brivio, E., Willemse, M. E., Huitema, A. D. R., Chandra, S., Vijayakumar, A., Van Der Velden, V. H. J., Beverloo, H. B., Durairaj, C., Viqueira, A., Ingrosso, A., Locatelli, F., Motwani, J., Bourquin, J.-P., Bautista Sirvent, F. J., Rizzari, C., Petit, A., Lancaster, D., Metzler, M., … Zwaan, C. M. (2021). A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children’s Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients. Blood, 138(Supplement 1), 2558–2558. https://doi.org/10.1182/blood-2021-145709
Authors:
Edoardo Pennesi
Erica Brivio
Marieke E. Willemse
Alwin D. R. Huitema
Saurabh Chandra
Ashwini Vijayakumar
Vincent H. J. van der Velden
H. Berna Beverloo
Chandra Durairaj
Andrea Viqueira
Antonella Ingrosso
Franco Locatelli
Jayashree Motwani
Jean‐Pierre Bourquin
Francisco Bautista
Carmelo Rizzari
Arnaud Petit
Donna Lancaster
Markus Metzler
Yves Bertrand
Laura Murillo
Andrew J. Bukowkinski
Julie Krystal
Inge M. van der Sluis
Michael Roth
Harm van Tinteren
Nobuko Hijiya
C. Michel Zwaan
Affiliated Authors:
Nobuko Hijiya
Publication Type:
Article
Unique ID:
10.1182/blood-2021-145709
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: